Virpax Pharmaceuticals Inc. (NASDAQ:VRPX) price on Wednesday, August 25, rose 17.04% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $17.17.
A look at the stock’s price movement, the close in the last trading session was $14.67, moving within a range at $14.77 and $18.50. Turning to its 52-week performance, $36.00 and $3.70 were the 52-week high and 52-week low respectively. Overall, VRPX moved 283.26% over the past month.
Virpax Pharmaceuticals Inc.’s market cap currently stands at around $94.26 million, with investors looking forward to this quarter’s earnings report slated for May 18, 2021.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s).
VRPX’s current price about 108.94% and 185.13% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 67.98, while 7-day volatility ratio is 24.12% and 21.90% in the 30-day chart. Further, Virpax Pharmaceuticals Inc. (VRPX) has a beta value of 0, and an average true range (ATR) of 3.18.
In the market, a comparison of Virpax Pharmaceuticals Inc. (VRPX) and its peers suggest the former has performed considerably stronger. Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are up 0.22% and 0.11% respectively in the last trading.
If we refocus on Virpax Pharmaceuticals Inc. (NASDAQ:VRPX), historical trading data shows that trading volumes averaged 5.95 million over the past 3 months. The company’s latest data on shares outstanding shows there are 4.96 million shares.
The 0.10% of Virpax Pharmaceuticals Inc.’s shares are in the hands of company insiders while institutional holders own 4.60% of the company’s shares. Current price change has pushed the stock 162.94% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the VRPX stock continues to rise going into the next quarter.